#Polyposis
"Recursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis"
ir.recursion.com
November 18, 2026 at 1:08 PM
#RXRX Recursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis

https://www.stocktitan.net/news/RXRX/recursion-announces-alignment-with-fda-on-registrational-phase-3-2wapfy4f564e.html?utm_source=stocktitan-bluesky&utm_medium=social
Recursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis
Recursion (RXRX) reached agreement with the FDA on the design of a Phase 3 trial of REC-4881 intended to support a future approval application.The trial will study the investigational oral drug in familial adenomatous polyposis (FAP), which has no approved drug therapies. The main measure is composite event-free survival, which tracks time until a qualifying event. Removal of an adenoma measuring 10 mm or larger in either the upper or lower gastrointestinal tract will count as one such event. Secondary measures include progression on the modified Spigelman scale and total polyp burden.Recursion expects the trial to start in the second half of 2027 and enroll approximately 200 adults with FAP who have had all or part of the colon removed, or both the colon and rectum removed.Recursion reported that its Phase 2 TUPELO trial showed reductions in polyp burden across the gastrointestinal tract, including larger, higher-risk polyps.
www.stocktitan.net
November 18, 2026 at 9:59 AM
Find out how otologic symptoms are important in chronic rhinosinusitis with nasal polyposis (CRSwNP) assessment and management from this study that evaluates the impact of dupilumab on ear-related symptoms in CRSwNP. www.annallergy.org/article/S108...
Impact of dupilumab on Sino-Nasal Outcome Test–22 (SNOT-22) domains: Focus on the ear
Chronic rhinosinusitis with nasal polyposis (CRSwNP) is frequently associated with otologic symptoms because of Eustachian tube dysfunction. However, the clinical relevance of otologic symptoms in pat...
www.annallergy.org
November 10, 2026 at 2:57 PM
Today, we're putting familial adenomatous polyposis (FAP) under the spotlight. 🔦

People with FAP have a fault in the APC gene. This fault can be passed on to their children. 🧬

#FAP #BowelCancer #HereditaryCancer #BowelCancerRisk #BowelPolyps
November 12, 2026 at 5:25 PM
Its NOT Familial adenomatous polyposis
November 2, 2026 at 6:05 PM
Serrated polyposis syndrome is easy to miss—and difficult to surveil well.

What do the 2026 USMSTF recommendations clarify about diagnosis, colon clearing, surveillance intervals, and family risk?

gastroagi.com/blog/serrate...
Serrated Polyposis Syndrome: 2026 USMSTF Recommendations
Review 2026 USMSTF recommendations for serrated polyposis syndrome, covering WHO diagnostic criteria, endoscopic management, surveillance and family screening.
gastroagi.com
October 27, 2026 at 7:51 AM
Disease severity, inflammatory endotype, comorbidities & patient preferences all play critical roles in chronic rhinosinusitis management. Whether to use biologics or functional endoscopic sinus surgery or a combination is explored in this review. www.annallergy.org/article/S108...
Biologics vs endoscopic surgery in the management of chronic rhinosinusitis with nasal polyps
Chronic rhinosinusitis with nasal polyposis is a heterogeneous inflammatory condition typically characterized by type 2 inflammatory responses. Patients who fail medical therapy (ie, nasal saline irri...
www.annallergy.org
October 27, 2026 at 2:03 PM
Foreman's Familial adenomatous polyposis Prank Ends in TEARS
October 25, 2026 at 10:06 AM
Parabilis Starts Zolucatetide Dose-Ranging FAP Study

Parabilis Medicines has initiated a new dose-ranging clinical cohort evaluating zolucatetide in adults with familial adenomatous polyposis (FAP…

Read more: https://embers.news/article/parabilis-starts-zolucatetide-dose-ranging-fap-study-520918
Parabilis Starts Zolucatetide Dose-Ranging FAP Study
Parabilis Medicines has initiated a new dose-ranging clinical cohort evaluating zolucatetide in adults with familial adenomatous polyposis (FAP) as part of an ongoing Phase 1/2 trial, building on early polyp reduction data. The study targets a rare genetic condition that currently lacks approved sys
embers.news
October 20, 2026 at 1:40 PM
A study in @jci.org led by @danafarber.bsky.social’s @sethilab.bsky.social on therapy-associated polyposis - which can develop decades after cancer treatment - identified lasting molecular evidence of genetic damage linked to chemotherapy in precancerous colorectal growths. ➡️bit.ly/4hIrB70
October 15, 2026 at 3:15 PM
The most likely diagnosis in this patient is?

A. gastric adenocarcinoma
B. familial polyposis
C. fundic gland polyps
D. GIST tumors

Find the answer here: ctisus.com/learning/qui...
October 14, 2026 at 8:39 PM
In this Research Letter, Nilay S. Sethi & team find chemotherapy leaves lasting DNA scars in precancerous colon polyps decades after treatment, helping explain the rare, late complication in childhood cancer survivors, therapy-associated polyposis: doi.org/10.1172/JCI2...
October 13, 2026 at 9:02 PM
Its NEVER Familial adenomatous polyposis
October 10, 2026 at 8:51 AM
A new case report in the Canadian Journal of Medical #Sonography (17.3) explores the role of transthoracic echocardiography and agitated saline studies in identifying complications of hereditary hemorrhagic telangiectasia and HHT–juvenile polyposis syndrome. Read more: bit.ly/CJMS17-3b
October 8, 2026 at 9:40 PM
American Journal of Gastroenterology Author Podcasts
ACG Clinical Guideline: Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes
American Journal of Gastroenterology Author Podcasts · Episode
open.spotify.com
October 7, 2026 at 11:41 AM
Comparator choice drove Germany’s assessment of depemokimab in severe nasal polyposis. https://www.mattheneus.com/editorial/g-ba-depemokimab-crswnp-final-resolution-active-biologic-comparator-gap-2026-10-01 #HTA #Pharma #RegulatoryAffairs
October 6, 2026 at 7:03 AM
ACG updates on colorectal polyposis, from screening to management. Source: ACG on YouTube. How will this guide care? https://www.youtube.com/watch?v=Uvo8UxSbtJQ
ACG Clinical Guideline: Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes
www.youtube.com
October 3, 2026 at 3:42 AM
Discover the new issue of the Canadian Journal of Medical #Sonography for new research on hereditary hemorrhagic telangiectasia and HHT–juvenile polyposis syndrome; the importance of intercultural competence training in Canadian sonographic practice; and more. Explore the issue: bit.ly/CJMS17-3
September 30, 2026 at 1:40 PM
Its NEVER Familial adenomatous polyposis
September 30, 2026 at 8:51 AM
This story presents a couple dealing with familial adenomatous polyposis as a compelling case for legalizing embryonic gene editing. I'm not an expert, but shouldn't mendelian diseases be more easily dealt with by preimplantation genetic testing? Isn't gene editing increased risk for no gain?
This startup wants to prove gene-editing embryos is safe for making healthy babies
Origin Genomics aims to prove that the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.
www.npr.org
September 29, 2026 at 11:31 PM
Geen woord over erfelijke aanleg voor darmkanker: Lynch of Polyposis. Dat heeft 1 op de 250 mensen.
September 28, 2026 at 6:30 AM